101 
Market Cap
As of July 16, 2010: $7,675,000.00
Stock Chart
Neuren Pharma - 30 Day Poll
Recent BLOGS About Neuren Pharma Add New
There are no blogs to display.
Latest Company News
|
SpringTree Special Opportunities Fund, LP Becomes Substantial Shareholder In Neuren Pharmaceuticals Ltd.
Reuters Key Development - Jul 21, 2010 |
|
Neuren Pharmaceuticals Ltd. Announces Conversion Of Convertible Note
Reuters Key Development - Jul 21, 2010 |
|
Neuren Pharmaceuticals Ltd. Announces Conversion Of Convertible Note
Reuters Key Development - May 21, 2010 |
|
Neuren Pharmaceuticals Begins NNZ-2566 Phase II Trial
Pharmaceutical Business Review - May 6, 2010 Neuren Pharmaceuticals, a biopharmaceutical company, has initiated Phase II clinical trial of NNZ-2566. The trial, designated Intrepid2566, is being conducted in collaboration with the US Army ...
|
|
Neuren Pharmaceuticals Ltd. Initiates Phase II Trial Of NNZ-2566
Reuters Key Development - May 5, 2010 |
|
Neuren Pharmaceuticals Ltd.'s Perseis Therapeutics Awarded Grant For The Trefoil Factor Inhibition Program
Reuters Key Development - Mar 18, 2010 |
Website
Videos related to Neuren Pharma
There are no videos to display.
Company Profile
Neuren Pharmaceuticals Limited (Neuren) is a biopharmaceutical company focusing on the development of drugs for neurological disorders, metabolism and cancer.
The drugs target acute indications of brain injury, such as cognitive impairment resulting from traumatic brain injury, psychiatric symptoms of stroke, as well as chronic conditions, such as Parkinson’s and Alzheimer’s diseases. Neuren has three lead candidates. Motiva and NNZ-2566, which is in clinical development to treat four different neurological conditions, and NNZ-2591 in preclinical development for Parkinson’s disease dementia and other chronic neurodegenerative conditions.
The Company has operations in New Zealand and the United States.
Terms & Rules
As per ASIC Regulatory Guide 162: All investment tips and comments appearing on this website (Poll results, BLOGS & discussion forums) are submitted by the general public who are not licensed financial advisors. None of the information on this website is financial or investment advice, you should seek independent financial or investment advice by a licensed financial or investment advisor before entering into any position of financial risk. Before using this website, you must agree to the BioInvesting.com.au Terms Of Use